3 min read
SGLT2 Inhibitors and Adverse Events: A Closer Look
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are an emerging class of medications that have become increasingly popular in medication regimens
Tag : Canagliflozin
3 min read
8 min read
Highlights From the February 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired
4 min read
SGLT2 Inhibitors and AKI: Time to Ditch the Dogma
Sodium/glucose cotransporter 2 inhibitors (SGLT2i / gliflozins) are a novel class of medications which act by inhibiting the SGLT2 transporter